JANUX THERAPEUTICS INC shareholders Q2 2023

JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 55 filers reported holding JANUX THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

JANUX THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
CITIGROUP INC 5,787$68,6910.00%
STATE OF WISCONSIN INVESTMENT BOARD 13,202$156,7080.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 46,121$547,4560.00%
GOLDMAN SACHS GROUP INC 22,719$269,6750.00%
MORGAN STANLEY 18,481$219,3680.00%
AMALGAMATED BANK 1,766$210.00%
BlackRock Inc. 1,194,588$14,179,7580.00%
Bank of New York Mellon Corp 53,049$629,6920.00%
Citadel Advisors 16,900$200,6030.00%
Citadel Advisors 1,400$16,6180.00%
ROYAL BANK OF CANADA 1,783$21,0000.00%
JANE STREET GROUP, LLC 14,935$177,2780.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 14,952$177,4800.00%
ALLIANCEBERNSTEIN L.P. 15,030$178,4060.00%
RHUMBLINE ADVISERS 26,778$317,8540.00%
Lindbrook Capital, LLC 125$1,4840.00%
Ameritas Investment Partners, Inc. 1,014$12,0360.00%
External links

This page lists JANUX THERAPEUTICS INC's shareholders in Q2 2023. To view JANUX THERAPEUTICS INC's shareholder history, click here.